Prof Dr. Yuqing Huo, Pharmaceutical Science, Best Researcher Award

Professor at Medical College of Georgia, Augusta Univ, United States

Summary:

Prof. Dr. Yuqing Huo is a distinguished cardiovascular biologist renowned for his contributions to understanding vascular inflammation and cardiovascular diseases. He obtained his medical degree from Jining Medical College in China and pursued postgraduate studies in cardiology at Qingdao University, followed by doctoral research in molecular cardiology at Beijing Medical University. Dr. Huo furthered his expertise through postdoctoral training in inflammation and vascular biology at the University of Virginia’s Cardiovascular Research Center.

Throughout his career, Dr. Huo has held academic appointments at esteemed institutions, including the University of Minnesota and Augusta University. He has served in various administrative roles and editorial positions for prestigious scientific organizations and journals, including the American Physiological Society and the American Journal of Physiology. Dr. Huo’s research focuses on elucidating the molecular mechanisms underlying vascular inflammation, atherosclerosis, and fibrosis, with a particular interest in ocular angiogenesis and subretinal fibrosis.

Professional Profile:

Scopus Profile

👩‍🎓Education:

Medical Degree (Clinical Medicine): Jining Medical College, Jining, P. R. China (1985-1989)

Master’s Degree (Cardiology): Qingdao University, Qingdao, P. R. China (1992-1995)

Doctoral Degree (Molecular Cardiology): Beijing Medical University, Beijing, P. R. China (1995-1998)

Postdoctoral Research Associate (Inflammation and Vascular biology): University of Virginia, Charlottesville, VA (1998-2001)

Professional Experience:

Dr. Yuqing Huo boasts a distinguished career in cardiovascular research spanning over three decades. After completing his medical education, Dr. Huo pursued postdoctoral training in inflammation and vascular biology at the University of Virginia. He then transitioned to academia, holding positions of increasing responsibility at renowned institutions such as the University of Minnesota and Augusta University. Throughout his career, Dr. Huo has made significant contributions to the understanding of vascular inflammation and molecular cardiology, leveraging his expertise to lead pioneering research projects funded by prestigious organizations like the National Institutes of Health. As Chief of the Vascular Inflammation Program and Director of the Vascular Biology Center, Dr. Huo continues to shape the field through his groundbreaking research, mentorship of aspiring scientists, and active involvement in professional organizations dedicated to cardiovascular health.

Research Interest:

Dr. Yuqing Huo’s research interests encompass various aspects of cardiovascular biology and inflammation, with a focus on understanding the molecular mechanisms underlying vascular diseases. His work delves into the role of inflammation in cardiovascular pathologies, particularly in conditions such as atherosclerosis, subretinal fibrosis, and ocular angiogenesis. Dr. Huo’s research investigates the interplay between immune cells, endothelial cells, and the microenvironment in driving vascular inflammation, aiming to uncover novel therapeutic targets for preventing and treating cardiovascular disorders. Additionally, he is keen on exploring the molecular pathways involved in tissue fibrosis and angiogenesis, with a particular emphasis on the role of metabolic dysregulation in promoting pathological vascular remodeling. Through his investigations, Dr. Huo seeks to advance our understanding of vascular biology and inflammation and develop innovative strategies for combating cardiovascular diseases.

Publications Top Noted:

Article Title: Type 1 Diabetes Impairs Endothelium-Dependent Relaxation Via Increasing Endothelial Cell Glycolysis Through Advanced Glycation End Products, PFKFB3, and Nox1-Mediated Mechanisms

Authors: Atawia, R.T., Batori, R.K., Jordan, C.R., … Fulton, D.J.R., Belin de Chantemèle, E.J.
Journal: Hypertension
Volume: 80
Issue: 10
Pages: 2059–2071
Year: 2023

Article Title: Purine synthesis suppression reduces the development and progression of pulmonary hypertension in rodent models

Authors: Ma, Q., Yang, Q., Xu, J., … Fulton, D.J.R., Huo, Y.
Journal: European Heart Journal
Volume: 44
Issue: 14
Pages: 1265–1279
Year: 2023

Article Title: Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity

Authors: Hu, X., Ma, Z., Li, S., … Manicassamy, S., Dong, Z.
Journal: Laboratory Investigation
Volume: 103
Issue: 3
Pages: 100009
Year: 2023

Article Title: PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4

Authors: Wen, L., Wei, Q., Livingston, M.J., … Huo, Y., Dong, Z.
Journal: Translational Research
Volume: 253
Pages: 31–40
Year: 2023

Article Title: Metabolic reprogramming through mitochondrial biogenesis drives adenosine anti-inflammatory effects: new mechanism controlling gingival fibroblast hyper-inflammatory state

Authors: Paladines, N., Dawson, S., Ryan, W., … Ramos-Junior, E.S., Morandini, A.C.
Journal: Frontiers in Immunology
Volume: 14
Pages: 1148216
Year: 2023

Yuqing Huo | Pharmaceutical Science | Best Researcher Award